ABIGAIL DEVEREAUX: Open Payments
NPI 1437528619 · FISHKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 36 payments from 12 companies in 2025. Trend: 2023 $767 · 2024 $794 · 2025 $831
Food & beverage: $722Education: $110
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $198 |
| ABBVIE INC. | 12 | $180 |
| Janssen Biotech, Inc. | 3 | $157 |
| GENZYME CORPORATION | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| UCB, Inc. | 1 | $34 |
| LEO Pharma Inc. | 1 | $23 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, TALTZ, Sotyktu, Zoryve, Bimzelx, RINVOQ.
Industry payments across NY — which companies pay providers there.
